$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls

$acls Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000110465914036345 Filed on May 08, 2014

Income Statement

Concept	2014 Q2	2014 Q1	2013 Q4
Revenue	$41.20M	$60.84M	$58.57M
YoY Change	-13.26%	49.39%	31.26%
Cost Of Revenue	$26.70M	$39.10M	$37.30M
YoY Change	-13.21%	40.73%	-15.42%
Gross Profit	$14.50M	$21.74M	$21.28M
YoY Change	-13.37%	67.97%	4333.33%
Gross Profit Margin	35.19%	35.73%	36.33%
Selling, General & Admin	$11.50M	$11.96M	$11.30M
YoY Change	-4.21%	1.41%	-16.3%
% of Gross Profit	79.31%	55.0%	53.1%
Research & Development	$8.800M	$9.257M	$8.900M
YoY Change	3.49%	0.55%	5.95%
% of Gross Profit	60.69%	42.58%	41.82%
Depreciation & Amortization	$1.160M	$1.140M	$1.130M
YoY Change	-12.78%	-18.22%	-22.6%
% of Gross Profit	8.0%	5.24%	5.31%
Operating Expenses	$20.30M	$21.41M	$20.20M
YoY Change	0.84%	-4.53%	-7.76%
Operating Profit	-$5.800M	$326.0K	$1.080M
YoY Change	70.89%	-103.44%	-105.04%
Interest Expense	-$300.0K	$251.0K	-$100.0K
YoY Change	-688.24%
% of Operating Profit		76.99%	-9.26%
Other Income/Expense, Net	-$400.0K	$43.00K	-$400.0K
YoY Change	10.5%	-94.83%	-20.0%
Pretax Income	-$6.700M	$369.0K	$500.0K
YoY Change	78.38%	-104.26%	-103.42%
Income Tax	$200.0K	$195.0K	-$100.0K
% Of Pretax Income		52.85%	-20.0%
Net Earnings	-$6.900M	$200.0K	$600.0K
YoY Change	72.5%	-102.22%	-104.05%
Net Earnings / Revenue	-16.75%	0.33%	1.02%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	-$248.2K	$0.00	$21.90K
COMMON SHARES
Basic Shares Outstanding	111.2M shares	110.6M shares	109.6M shares
Diluted Shares Outstanding		115.8M shares

Balance Sheet

Concept	2014 Q2	2014 Q1	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.60M	$43.00M	$46.30M
YoY Change	2.89%	1.42%	2.89%
Cash & Equivalents	$35.60M	$43.04M	$46.29M
Short-Term Investments
Other Short-Term Assets	$7.600M	$7.500M	$6.200M
YoY Change	24.59%	33.93%	19.23%
Inventory	$106.7M	$95.53M	$95.79M
Prepaid Expenses
Receivables	$32.10M	$38.12M	$36.59M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$181.9M	$184.2M	$184.9M
YoY Change	8.66%	8.37%	5.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.30M	$31.61M	$32.01M
YoY Change	-5.05%	-6.11%	-6.99%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.40M	$16.10M	$15.81M
YoY Change	-0.04%	30.38%	26.28%
Total Long-Term Assets	$44.70M	$48.53M	$48.64M
YoY Change	-3.6%	5.47%	3.64%
TOTAL ASSETS
Total Short-Term Assets	$181.9M	$184.2M	$184.9M
Total Long-Term Assets	$44.70M	$48.53M	$48.64M
Total Assets	$226.6M	$232.7M	$233.5M
YoY Change	6.0%	7.75%	5.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$17.40M	$17.87M	$19.45M
YoY Change	7.49%	29.52%	91.33%
Accrued Expenses	$4.000M	$4.700M	$4.800M
YoY Change	-39.39%	-47.19%	-34.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.100M	$762.0K	$471.0K
YoY Change
Total Short-Term Liabilities	$32.10M	$33.23M	$35.46M
YoY Change	-7.1%	-2.48%	19.07%
LONG-TERM LIABILITIES
Long-Term Debt	$13.90M	$14.24M	$14.53M
YoY Change
Other Long-Term Liabilities	$7.200M	$7.058M	$7.236M
YoY Change	23.52%	23.54%	23.82%
Total Long-Term Liabilities	$21.10M	$21.30M	$21.77M
YoY Change	261.98%	272.76%	272.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.10M	$33.23M	$35.46M
Total Long-Term Liabilities	$21.10M	$21.30M	$21.77M
Total Liabilities	$53.30M	$54.78M	$57.55M
YoY Change	31.15%	36.59%	59.49%
SHAREHOLDERS EQUITY
Retained Earnings		-$339.4M	-$339.6M
YoY Change		2.41%	5.32%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.218M	$1.218M
YoY Change		0.0%	0.0%
Treasury Stock Shares		120.0K shares	120.0K shares
Shareholders Equity	$173.3M	$177.9M	$176.0M
YoY Change
Total Liabilities & Shareholders Equity	$226.6M	$232.7M	$233.5M
YoY Change	6.0%	7.75%	5.13%

Cashflow Statement

Concept	2014 Q2	2014 Q1	2013 Q4
OPERATING ACTIVITIES
Net Income	-$6.900M	$200.0K	$600.0K
YoY Change	72.5%	-102.22%	-104.05%
Depreciation, Depletion And Amortization	$1.160M	$1.140M	$1.130M
YoY Change	-12.78%	-18.22%	-22.6%
Cash From Operating Activities	-$7.900M	-$3.960M	-$4.190M
YoY Change	-11.43%	110.64%	-644.16%
INVESTING ACTIVITIES
Capital Expenditures	-$340.0K	$227.0K	-$340.0K
YoY Change	78.95%	51.33%	580.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$1.590M
YoY Change	-100.0%	-100.0%	-81.75%
Cash From Investing Activities	-$340.0K	-$230.0K	$1.250M
YoY Change	-154.84%	-192.0%	-85.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	530.0K	1.280M	710.0K
YoY Change	51.43%	2460.0%	173.08%
NET CHANGE
Cash From Operating Activities	-7.900M	-3.960M	-4.190M
Cash From Investing Activities	-340.0K	-230.0K	1.250M
Cash From Financing Activities	530.0K	1.280M	710.0K
Net Change In Cash	-7.710M	-2.910M	-2.230M
YoY Change	-3.02%	84.18%	-123.01%
FREE CASH FLOW
Cash From Operating Activities	-$7.900M	-$3.960M	-$4.190M
Capital Expenditures	-$340.0K	$227.0K	-$340.0K
Free Cash Flow	-$7.560M	-$4.187M	-$3.850M
YoY Change	-13.4%	106.26%	-569.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1200000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2103634	shares
CY2013Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8988000	USD
CY2014Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	5825000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	174000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5739000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-677000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5068000	USD
CY2014Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax	-6000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-671000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	12000	USD
CY2013Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	56942000	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	27462000	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11385000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	95789000	USD
CY2014Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	57809000	USD
CY2014Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	29064000	USD
CY2014Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8660000	USD
CY2014Q1	us-gaap	Inventory Net InventoryNet	95533000	USD
CY2014Q1	acls	Charges Related To Below Normal Production Capacity ChargesRelatedToBelowNormalProductionCapacity	0	USD
CY2013Q1	acls	Charges Related To Below Normal Production Capacity ChargesRelatedToBelowNormalProductionCapacity	500000	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1428000	USD
CY2014Q1	acls	Product Warranty Period ProductWarrantyPeriod	P1Y
CY2013Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1582000	USD
CY2012Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1801000	USD
CY2014Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1620000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	457000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	399000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-277000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1539000	USD
CY2013Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	43000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1496000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	124000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	647000	USD
CY2014Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	467000	USD
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	AXCELIS TECHNOLOGIES INC
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001113232
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9257000	USD
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	111202573	shares
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	34452000	USD
CY2013Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	6274000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	40726000	USD
CY2013Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	22181000	USD
CY2013Q1	us-gaap	Cost Of Services CostOfServices	5602000	USD
CY2013Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	27783000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	12943000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9206000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5201000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6590000	USD
CY2013Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	368000	USD
CY2013Q1	us-gaap	Restructuring Charges RestructuringCharges	1801000	USD
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	22430000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9487000	USD
CY2013Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	829000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	832000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8655000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	333000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	60840000	USD
CY2014Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39100000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	21740000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	21414000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	326000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	43000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	369000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2078000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	8000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	56000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	839000	USD
CY2013Q1	us-gaap	Inventory Write Down InventoryWriteDown	2211000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1458000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19451000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4845000	USD
CY2013Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1316000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	417000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4387000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	471000	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4573000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	35460000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14529000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	322000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7236000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	57547000	USD
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	110000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	510992000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1218000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-339621000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	176002000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1672000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	544000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5043000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11058000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-497000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46290000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36587000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6242000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	184908000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32006000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	825000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15810000	USD
CY2014Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	USD
CY2013Q4	us-gaap	Assets Assets	233549000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	233549000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	177925000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	232703000	USD
CY2014Q1	us-gaap	Liabilities Liabilities	54778000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	33225000	USD
CY2014Q1	us-gaap	Assets Assets	232703000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	184169000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	110225000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	110105000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	120000	shares
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	111269000	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	111149000	shares
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	400000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	150000	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-3000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-843000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	84000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	549000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1879000	USD
CY2014Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	120000	shares
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1394000	USD
CY2014Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	762000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	253000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	49000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	49000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-968000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-2545000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-3251000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1277000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-227000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3963000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43039000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44986000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42441000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1277000	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5476000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6481000	USD
CY2014Q1	us-gaap	Restructuring Charges RestructuringCharges	200000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2014Q1	us-gaap	Interest Expense InterestExpense	251000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	292000	USD
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	195000	USD
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110649000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	115798000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108227000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108227000	shares
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2014Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-677000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	6000	USD
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38121000	USD
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7476000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31605000	USD
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	825000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16104000	USD
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	17865000	USD
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4692000	USD
CY2014Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	474000	USD
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3836000	USD
CY2014Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4100000	USD
CY2014Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	14238000	USD
CY2014Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	257000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7058000	USD
CY2014Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	111000	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	513411000	USD
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1218000	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-339447000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1140000	USD
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	312000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1172000	USD
CY2014Q1	us-gaap	Inventory Write Down InventoryWriteDown	59000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1634000	USD
CY2014Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	52000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1252000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2025000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-614000	USD
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5149000	shares
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance Noncurrent DeferredTaxAssetsValuationAllowanceNoncurrent	147500000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	61000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1304000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	227000	USD
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-338000	USD

Files In Submission

Name	View Source	Status
0001104659-14-036345-index-headers.html	Edgar Link	pending
0001104659-14-036345-index.html	Edgar Link	pending
0001104659-14-036345.txt	Edgar Link	pending
0001104659-14-036345-xbrl.zip	Edgar Link	pending
a14-8383_110q.htm	Edgar Link	pending
a14-8383_1ex31d1.htm	Edgar Link	pending
a14-8383_1ex31d2.htm	Edgar Link	pending
a14-8383_1ex32d1.htm	Edgar Link	pending
a14-8383_1ex32d2.htm	Edgar Link	pending
acls-20140331.xml	Edgar Link	completed
acls-20140331.xsd	Edgar Link	pending
acls-20140331_cal.xml	Edgar Link	unprocessable
acls-20140331_def.xml	Edgar Link	unprocessable
acls-20140331_lab.xml	Edgar Link	unprocessable
acls-20140331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls

2014 Q2 Form 10-Q Financial Statement

#000110465914036345 Filed on May 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACLS AXCELIS TECHNOLOGIES INC Stock $acls

2014 Q2 Form 10-Q Financial Statement

#000110465914036345 Filed on May 08, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACLS
AXCELIS TECHNOLOGIES INC Stock $acls